Search

Search Constraints

You searched for: Author/Creator Ruet, Aurelie

Search Results

2. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022)

3. Efficacy of rituximab in refractory RRMS. (May 2019)

4. Time to steroids impacts visual outcome of optic neuritis in MOGAD. Issue 4 (13th December 2022)